Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
BMC Ophthalmol ; 18(1): 148, 2018 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-29929478

RESUMEN

BACKGROUND: To study the clinical outcomes of pigment epithelial detachment (PED) associated with neovascular age-related macular degeneration (nAMD) in patients switched from Ranibizumab to Aflibercept. METHODS: Retrospective non-comparative case series. 50 eyes with active nAMD and fovea involving PED of ≥100 µm measured manually using the caliper on the OCT, initially treated with intravitreal Ranibizumab (0.5 mg/0.05 ml) and later switched to Aflibercept (2.0 mg/0.05 ml). The outcome measures of best corrected visual acuity (BCVA), PED height, PED width and number of injections were measured at baseline and at time point of switch, 4 months, 1 year and at last follow up visit post-switch. Three paired t-tests and Pearson's correlations were calculated to analyze variables at switch and change in variables at 1 year. RESULTS: After switch to Aflibercept, the improvement of BCVA was 1.84 (p = 0.11), 1.74 (p = 0.21) and 1.16 (p = 0.45) letters, the change in PED height was - 65.6µm (p < 0.001), - 50.64µm (p = 0.007) and - 68.48µm (p < 0.001) and the change in PED width was - 36.6µm (p = 0.514), + 29.7µm (p = 0.922) and + 118.4µm (p = 0.210) at 4 months, 1 year and the last visit respectively. There was a moderate negative correlation between reduction in PED height at 1 year after switch and PED height at the time of switch to Aflibercept (r = - 0.474, p < 0.05). CONCLUSION: The improvement in BCVA and change in PED width was not statistically significant however the reduction in PED height was significant after switching treatment to Aflibercept. The change in BCVA at 1 year after switch was not correlated with any of the analyzed anatomical characteristics of PED.


Asunto(s)
Sustitución de Medicamentos/métodos , Ranibizumab/administración & dosificación , Receptores de Factores de Crecimiento Endotelial Vascular/administración & dosificación , Proteínas Recombinantes de Fusión/administración & dosificación , Desprendimiento de Retina/tratamiento farmacológico , Epitelio Pigmentado de la Retina/patología , Agudeza Visual/fisiología , Degeneración Macular Húmeda/complicaciones , Anciano , Anciano de 80 o más Años , Inhibidores de la Angiogénesis/administración & dosificación , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Estudios de Seguimiento , Humanos , Inyecciones Intravítreas , Masculino , Persona de Mediana Edad , Receptores de Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Desprendimiento de Retina/etiología , Desprendimiento de Retina/patología , Estudios Retrospectivos , Factores de Tiempo , Tomografía de Coherencia Óptica , Resultado del Tratamiento , Degeneración Macular Húmeda/diagnóstico , Degeneración Macular Húmeda/tratamiento farmacológico
2.
Ophthalmic Genet ; 38(2): 183-186, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27268268

RESUMEN

BACKGROUND: Mulvihill-Smith syndrome is a rare progeroid syndrome of sporadic nature. Previously reported ophthalmological findings include astigmatism, myopia, endothelial dystrophy, keratoconus, cataract, band keratopathy, meibomian gland dysfunction, dry eye disease, amblyopia, and allergic conjunctivitis. MATERIALS AND METHODS: The proband, a 25-year-old male subject diagnosed with Mulvihill-Smith syndrome in childhood developed retinal changes with onset of adulthood. The retinal changes were monitored for progression with fundus photography, electrodiagnostic tests, and spectral domain optical coherence tomography. RESULTS: The fundus examination revealed grossly normal looking retina with dull foveal reflex. The optical coherence tomography scan of the retina revealed diffuse thickening, schisis, and folding of retinal layers in both eyes. The structural changes in retina were progressive with wrinkling of inner retinal layers and loss of foveal contour as observed over 3 years. The electrodiagnostic tests revealed normal photoreceptor-retinal pigment epithelial interface. CONCLUSIONS: This is the first report of retinal features in Mulvihill-Smith syndrome. These ocular changes coincided with other systemic changes with the onset of adulthood. These changes may indicate the natural history of retinal features in this progeria syndrome with short life span. The detailed analysis and progression of structural changes in retina is possible with optical coherence tomography.


Asunto(s)
Trastornos del Crecimiento/diagnóstico , Nevo Pigmentado/diagnóstico , Progeria/diagnóstico , Enfermedades de la Retina/diagnóstico , Adulto , Electrooculografía , Electrorretinografía , Angiografía con Fluoresceína , Trastornos del Crecimiento/fisiopatología , Humanos , Masculino , Nevo Pigmentado/fisiopatología , Células Fotorreceptoras de Vertebrados/fisiología , Progeria/fisiopatología , Enfermedades de la Retina/fisiopatología , Tomografía de Coherencia Óptica , Agudeza Visual/fisiología
3.
Quant Imaging Med Surg ; 6(3): 318-9, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27429917

RESUMEN

A 16-year-old Caucasian male presented with non-specific acute respiratory symptoms, on a background of irritable bowel syndrome and type 2 diabetes mellitus. Clinical examination and initial imaging were highly suggestive of a pleural effusion. Routine confirmatory ultrasound imaging prompted subsequent computed tomography scanning, revealing striking images of a Bochdalek hernia, therefore enabling appropriate subsequent management and avoiding patient harm.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA